Skip to main content

Table 2 Patient characteristics

From: The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients

  

Adenocarcinoma

Squamous cell carcinoma

Age

   
 

Male

64.2 ± 8.5 (n = 41)

66.0 ± 8.1 (n = 73)

 

Female

59.2 ± 10.8 (n = 34)

67.7 ± 10.0 (n = 6)

Smoking habit

   
 

Never

35 (46.7%)

7 (8.9%)

 

Smoker

40 (53.3%)

72 (91.1%)

Stage

   
 

Stage I + II

14 (18.7%)

12 (15.2%)

 

Stage III + IV

61 (81.3%)

67 (84.8%)

T stage

   
 

1

12 (16.0%)

4 (5.1%)

 

2

2 (2.7%)

8 (10.1%)

 

3

19 (25.3%)

43 (54.4%)

 

4

42 (56.0%)

24 (30.4%)